Pyxis Oncology (PYXS) Earnings Analysis

Pyxis Oncology (PYXS) next reports earnings on 2026-08-13, consensus EPS -0.34 USD. Last quarter (2026-05-14) it missed with EPS -0.37 USD vs -0.35 USD est (-5.7%). It has beaten estimates in 5/7 recent quarters (71%). Trailing P/E -1.93.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does PYXS next report earnings?

Next earnings date2026-08-13
Consensus EPS estimate-0.34 USD
Revenue estimate0.00B

PYXS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-14-0.37 USD-0.35 USD-5.7%Miss
2026-03-23-0.29 USD-0.35 USD+17.1%Beat
2025-11-03-0.35 USD-0.36 USD+2.8%Beat
2025-08-14-0.3 USD-0.36 USD+16.7%Beat
2025-05-15-0.35 USD-0.29 USD-20.7%Miss
2025-03-18-0.32 USD-0.33 USD+3%Beat
2024-08-14-0.29 USD-0.33 USD+12.1%Beat

Beat rate: 5/7 (71%) over reported quarters with consensus data.

PYXS valuation and analyst view

Trailing P/E-1.93
Trailing EPS-1.28778 USD
Price / book5.14
Dividend yield0.00%
Market cap0.14B
Analyst consensusBuy (8 buy / 2 hold / 0 sell)
Avg price target6.5 USD

Related research pages

Frequently asked questions

When is Pyxis Oncology (PYXS)'s next earnings date?

Pyxis Oncology is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.34 USD and revenue estimate of 0.00B.

Did PYXS beat earnings last quarter?

In its 2026-05-14 report, PYXS posted EPS of -0.37 USD versus a -0.35 USD estimate — a miss of 5.7%.

What is PYXS's earnings track record?

Over the last 7 reported quarters with consensus data, PYXS beat estimates 5 times (71%).

What is PYXS's current P/E ratio and EPS?

PYXS trades at a trailing P/E of -1.93 on trailing EPS of -1.2877767948088739 USD.

What do analysts rate PYXS?

Analyst consensus is "Buy" across 10 ratings (0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 6.5 USD.